Literature DB >> 11557726

Latent tuberculosis may persist for over 40 years.

A O'Regan, M Joyce-Brady.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11557726      PMCID： PMC1121202     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline.

Authors:  M S Glickman; W R Jacobs
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Treatment of tuberculous meningitis.

Authors:  J G KERR
Journal:  Br Med J       Date:  1953-11-21

3.  Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.

Authors:  J D McKinney; K Höner zu Bentrup; E J Muñoz-Elías; A Miczak; B Chen; W T Chan; D Swenson; J C Sacchettini; W R Jacobs; D G Russell
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

4.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962
  4 in total
  6 in total

1.  The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon.

Authors:  Abebech Demissie; Liya Wassie; Markos Abebe; Abraham Aseffa; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Cloning, expression, purification, crystallization and preliminary X-ray crystallographic analysis of bacterioferritin A from Mycobacterium tuberculosis.

Authors:  Vibha Gupta; Rakesh K Gupta; Garima Khare; Dinakar M Salunke; Anil K Tyagi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-04-24

3.  Structure and function of Rv0130, a conserved hypothetical protein from Mycobacterium tuberculosis.

Authors:  Patrik Johansson; Alina Castell; T Alwyn Jones; Kristina Bäckbro
Journal:  Protein Sci       Date:  2006-09-08       Impact factor: 6.725

4.  The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase.

Authors:  Anthony J Harrison; Minmin Yu; Therés Gårdenborg; Martin Middleditch; Rochelle J Ramsay; Edward N Baker; J Shaun Lott
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

Review 5.  Vaccines for tuberculosis: novel concepts and recent progress.

Authors:  T Mark Doherty; Peter Andersen
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

6.  Crystal structure of Bfr A from Mycobacterium tuberculosis: incorporation of selenomethionine results in cleavage and demetallation of haem.

Authors:  Vibha Gupta; Rakesh K Gupta; Garima Khare; Dinakar M Salunke; Anil K Tyagi
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.